favorable-risk rcc: factors in selecting therapy
Published 4 years ago • 69 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
4:28
prognostic factors and treatment selection in rcc
-
1:55
favorable traits in metastatic rcc
-
8:46
metastatic rcc: selecting therapy at recurrence
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
4:06
selecting therapy for poor-risk advanced rcc
-
10:24
the typical prognosis of aggressive renal cell cancer
-
7:52
frontline treatment options for stage 4 rcc
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
2:50
factors considered when choosing rcc treatment options
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
7:43
deferred therapy for favorable-risk mrcc patients
-
4:06
selecting second-line therapy for metastatic rcc
-
4:27
vegf-tki therapy in first-line mrcc
-
3:54
treating intermediate and favorable-risk renal cell carcinoma
-
6:36
choosing post-progression therapy for metastatic rcc
-
9:52
factors in selecting immunotherapy or tki inhibition
-
5:12
advanced rcc: prognosis and therapy selection
-
4:09
favorable-risk rcc: options for vegf tki monotherapy
-
5:20
ep. 11: factors in selecting therapy for mcrpc
-
7:18
vegf tki therapy in the adjuvant setting of rcc
-
3:11
treatment options for intermediate/poor-risk rcc
-
1:12
dr. agarwal on second-line therapy selection in metastatic rcc